Introducing Verkazia

The first and only medicine of its kind studied in children with vernal keratoconjunctivitis (VKC)

Introducing Verkazia

The first and only medicine of its kind studied in children with vernal keratoconjunctivitis (VKC)

Verkazia is a safe, effective, long-term solution that helps break the cycle of VKC. It is FDA-approved to treat VKC in children and adults.

Verkazia is not a steroid and can be used without other medications

Learn how Verkazia works

Verkazia helps your kid get back to being a kid

Verkazia is a safe, effective, long-term solution that helps break the cycle of VKC. It is FDA-approved to treat VKC in children and adults.

Verkazia is not a steroid and can be used without other medications

Learn how Verkazia works

Verkazia helps kids get back to being kids

Verkazia helps break the cycle of VKC by working with the immune system

Image

Verkazia is an immunomodulator called cyclosporine. It helps stop the activity in the immune system that causes VKC symptoms.
Image

Verkazia uses a unique formulation to make sure the eye gets enough cyclosporine to effectively treat VKC.
Image

Verkazia every day, 4 times per day, keeps VKC at bay. Your doctor will help decide how long you or your child should take Verkazia.

Verkazia was tested in children and proven effective

Verkazia was studied in more than 100 children in a 12-month-long clinical trial

Verkazia helped improve symptoms like light sensitivity, itching, tearing, and mucous discharge within the first month of using Verkazia

Verkazia helped soothe the inflammation that can cause damage to the clear part of the eye called the cornea

Verkazia reduces symptoms within a month

Verkazia is safe to use for long periods of time

Verkazia has few side effects. Most side effects occur when the eye drop is given, and go away quickly.

The most common side effects are pain, itching, and discomfort with the drop.

VKC is a rare eye disease that can cause unpredictable symptoms year-round

Fast facts about VKC

~49k
Cases

VKC is rare. In 2017, there were about 49,000 cases of VKC diagnosed in the United States.
Many symptoms

VKC has many symptoms. These include sensitivity to light, itching, tearing, or discharge from the eye. It may also cause dots on the white of the eye or bumps underneath the eyelid.
Not contagious

VKC is different from pink eye (conjunctivitis). VKC is often mistaken for pink eye because it has many of the same symptoms such as redness, itching, and mucous discharge. Unlike some forms of pink eye, VKC is never contagious.
<10 YEARS

VKC usually begins before children are 10 years old, and often goes away during adolescence. It can continue into adulthood in rare cases.
50^%

VKC has many causes. Only about 50% of people with VKC have an allergy that triggers symptoms. Others have no clear cause and may experience symptoms outside of the allergy season.

Vernal keratoconjunctivitis is not pink eye

For many people, there is no clear cause for VKC symptoms

Learn how Verkazia works

Learn about how Verkazia works to control VKC

Verkazia’s patient access support program will help you every step of the way

The Verkazia patient access support program will help you navigate the path to relief. Find out if you’re eligible for financial help, review educational materials, and get answers to common questions by filling out the service request form at the Verkazia patient access support webpage or by calling 1-833-577-7277 (8 am to 8 pm ET M-F) to enroll.

Enroll now

Resources for you and your family

Image

English

Download a brochure about VKC and Verkazia for parents, teachers, and school nurses
Download
Image

Español

Descargue un folleto sobre la QCV y Verkazia para padres, profesores y enfermeras escolares
Descargar
Image

Download a storybook to bring reassurance to a child with VKC
Download
Image

Download this calendar to track treatment and motivate the VKC patient in your life. Select “fit to printable area” when printing
Download

Other online resources about VKC

Vernal Keratoconjunctivitis (VKC)—Kellogg Eye Center of University of Michigan Health >

Living With VKC—Santen Inc >

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Potential for eye injury and contamination: To avoid the potential for eye injury and contamination, advise patient not to touch the vial tip to the eye or other surfaces.

Adverse Reactions

The most common adverse reactions reported in greater than 5% of patients were eye pain (12%) and eye pruritus (8%), which were usually transitory and occurred during instillation.

You are encouraged to report adverse reactions of prescription drugs to Santen at 1-855-7-SANTEN (1-855-772-6836). Or you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

IMPORTANT SAFETY INFORMATION

Be careful not to touch the vial tip to your eye or other surfaces, to help avoid potential eye injury or contamination of the product.

Contact lenses should be removed before applying Verkazia and may be reinserted 15 minutes after instillation.

The most common side effect is a temporary burning sensation. Other side effects include eye redness, eye discomfort, itchiness, and foreign body sensation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here to see the full Product Information.

Introducing Verkazia

Introducing Verkazia

Verkazia helps kids get back to being kids

Verkazia was studied in more than 100 children in a 12-month-long clinical trial

Verkazia is safe to use for long periods of time

VKC is a rare eye disease that can cause unpredictable symptoms year-round

Learn how Verkazia works

Verkazia’s patient access support program will help you every step of the way

Resources for you and your family

Other online resources about VKC

INDICATIONS AND USAGE

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Adverse Reactions

WHAT IS VERKAZIA?

IMPORTANT SAFETY INFORMATION

Get in touch

THANK YOU FOR YOUR INTEREST